Valued at BT129bn ($4.11bn) in 2011 by the Board of Investment (BOI), Thailand’s pharmaceuticals industry continue to ride high on growing domestic and export demand. These prospects are expected to push market value to BT225bn ($7.18bn) by 2019, in which time Thailand’s own Government Pharmaceutical Organisation (GPO) is hoping to tap into the 2015...
Investment in Thailand’s health care services over the last 40 years have created an internationally lauded system and a paragon for lower- and middle-income economies. Yet as the nation’s economy has prospered, Thailand is facing a growing occurrence of chronic, non-communicable diseases among its ageing adult population, leading to a trend in...
The advent of the ASEAN Economic Community (AEC) in 2015, has presented Thailand and the Ministry of Education (MoE) with a shift in the region’s status quo that has required wholesale reform of the education system (see overview). Yet the AEC also presents opportunities for Thailand to capitalise on international demands for education across all...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×
